LeishVet update and recommendations on feline leishmaniosis

Maria Grazia Pennisi, Luís Cardoso, Gad Baneth, Patrick Bourdeau, Alek Koutinas, Guadalupe Miró, Gaetano Oliva, Laia Solano-Gallego

Research output: Contribution to journalReview articleResearchpeer-review

74 Citations (Scopus)

Abstract

© 2015 Pennisi et al. Limited data is available on feline leishmaniosis (FeL) caused by Leishmania infantum worldwide. The LeishVet group presents in this report a review of the current knowledge on FeL, the epidemiological role of the cat in L. infantum infection, clinical manifestations, and recommendations on diagnosis, treatment and monitoring, prognosis and prevention of infection, in order to standardize the management of this disease in cats. The consensus of opinions and recommendations was formulated by combining a comprehensive review of evidence-based studies and case reports, clinical experience and critical consensus discussions. While subclinical feline infections are common in areas endemic for canine leishmaniosis, clinical illness due to L. infantum in cats is rare. The prevalence rates of feline infection with L. infantum in serological or molecular-based surveys range from 0 % to more than 60 %. Cats are able to infect sand flies and, therefore, they may act as a secondary reservoir, with dogs being the primary natural reservoir. The most common clinical signs and clinicopathological abnormalities compatible with FeL include lymph node enlargement and skin lesions such as ulcerative, exfoliative, crusting or nodular dermatitis (mainly on the head or distal limbs), ocular lesions (mainly uveitis), feline chronic gingivostomatitis syndrome, mucocutaneous ulcerative or nodular lesions, hypergammaglobulinaemia and mild normocytic normochromic anaemia. Clinical illness is frequently associated with impaired immunocompetence, as in case of retroviral coinfections or immunosuppressive therapy. Diagnosis is based on serology, polymerase chain reaction (PCR), cytology, histology, immunohistochemistry (IHC) or culture. If serological testing is negative or low positive in a cat with clinical signs compatible with FeL, the diagnosis of leishmaniosis should not be excluded and additional diagnostic methods (cytology, histology with IHC, PCR, culture) should be employed. The most common treatment used is allopurinol. Meglumine antimoniate has been administered in very few reported cases. Both drugs are administered alone and most cats recover clinically after therapy. Follow-up of treated cats with routine laboratory tests, serology and PCR is essential for prevention of clinical relapses. Specific preventative measures for this infection in cats are currently not available.
Original languageEnglish
Article number302
Pages (from-to)302-
JournalParasites and Vectors
Volume8
Issue number1
DOIs
Publication statusPublished - 4 Jun 2015

Keywords

  • Diagnosis
  • Epidemiology
  • Feline leishmaniosis
  • Leishmania infantum
  • Prevention
  • Prognosis
  • Recommendations
  • Treatment

Fingerprint Dive into the research topics of 'LeishVet update and recommendations on feline leishmaniosis'. Together they form a unique fingerprint.

Cite this